PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Symptom | |diabetes mellitus |
| Sentences | 137 |
| PubMedID- 20920303 | If hypertension and chronic renal disease co-exist, as is common in patients with diabetes mellitus, the risk of cardiovascular disease is heightened. |
| PubMedID- 23227510 | A current model for predicting the risk of cardiovascular diseases in patients with type 2 diabetes mellitus. |
| PubMedID- 25256018 | Aims: this study aimed to investigate the impact of early-onset diabetes on the risk of microvascular diseases in chinese with type 2 diabetes mellitus (t2dm). |
| PubMedID- 21088641 | All had a history of diabetes mellitus with peripheral vascular disease. |
| PubMedID- 24855344 | Several large-scale, prospective, randomized trials have documented that lowering glycemic levels can prevent the development of microvascular disease in people with type 2 diabetes mellitus (t2dm). |
| PubMedID- 20653327 | Therapeutic potential of aleglitazar, a new dual ppar-alpha/gamma agonist: implications for cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 26485682 | Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity . |
| PubMedID- 21398276 | Circulating angiopoietic cells and diabetic retinopathy in type 2 diabetes mellitus, with or without macrovascular disease. |
| PubMedID- 25214836 | Left ventricular hypertrophy (lvh) and albuminuria are both markers for cardiovascular diseases (cvds) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 21632491 | Sensitive cardiac troponin t assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the women's health study. |
| PubMedID- 24465187 | Hrs were adjusted for cohort as a random effect and for sex, age, body mass index, smoking, total cholesterol, diabetes mellitus, and history of cardiovascular disease as fixed effects. |
| PubMedID- 19875998 | The impact of obesity on cardiovascular disease (cvd) outcomes in patients with type 2 diabetes mellitus (t2dm) and established coronary artery disease (cad) is controversial; whether bmi and/or waist circumference correlate with atherothrombotic risk factors in such patients is uncertain. |
| PubMedID- 21990060 | Cardiovascular disease patients with diabetes mellitus type 2. |
| PubMedID- 20210989 | In a more recent controlled study performed in our center 6, it was found that blood flow alterations (stenoses and/or occlusions) demonstrated in temporal arteries with doppler ultrasonography are neither specific nor sensitive for gca, since these findings were equally common among elderly individuals or patients with macrovascular disease associated with diabetes mellitus or stroke, due to the temporal artery atherosclerotic changes. |
| PubMedID- 22906083 | Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care. |
| PubMedID- 22994452 | Regarding cardiovascular mortality, age, diabetes mellitus, history of cardiovascular disease, lvmi, lvef, cimt, and pwv were significant predictors (table2). |
| PubMedID- 25179966 | Peripheral neuropathy may be a potential risk of cardiovascular disease in diabetes mellitus. |
| PubMedID- 22447230 | This manuscript presents an overview of the biology of the haptoglobin genotype and reviews the literature concerning its role in the development of cardiovascular disease among individuals with diabetes mellitus. |
| PubMedID- 20920271 | However, with the occurrence of dysfunction, the endothelium is a potential contributor to the pathogenesis of vascular disease in diabetes mellitus and atherosclerosis . |
| PubMedID- 26318399 | Association between cetp gene polymorphism, insulin resistance and risk of diabetes mellitus in patients with vascular disease. |
| PubMedID- 19859073 | The burden of microvascular disease in patients with type 2 diabetes mellitus continues to escalate worldwide. |
| PubMedID- 24158454 | The framingham stroke prediction algorithm (http://www.framinghamheartstudy.org/risk/stroke.html) included sbp values and age, diabetes mellitus, smoking, history of cardiovascular disease, presence of atrial fibrillation, left ventricular hypertrophy and the use of hypertensive medication. |
| PubMedID- 23130159 | Patients with non-st-segment-elevation myocardial infarction were older, more likely to be women, and more likely to have hypertension, diabetes mellitus, and a history of past cardiovascular disease than were patients with st-elevation myocardial infarction. |
| PubMedID- 20847892 | Evidence suggests that the maintenance of a large muscle mass may reduce metabolic risk factors—namely, obesity, dyslipidaemia, and type 2 diabetes mellitus—associated with cardiovascular disease . |
| PubMedID- 22665334 | As an example, cpgs for cardiovascular diseases in diabetes mellitus have been developed.24 these cpgs contain detailed practical instructions for management of cardiovascular diseases in diabetic patients.24 some studies have reported that cpgs can improve the health outcomes of patients in terms of in-hospital mortality or los and concluded that cpgs were a significant independent predictor of clinical outcomes of patients.25,26 therefore, we think that the preparation and institution of cpgs for bleeding peptic ulcers with comorbid diabetes mellitus would be a promising policy implementation for improving the short-term clinical outcomes of these patients. |
| PubMedID- 26246173 | Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the american heart association and the american diabetes association. |
| PubMedID- 25238222 | What is it about very low density lipoproteins (vldl) and cardiovascular disease in patients with type 2 diabetes mellitus: is it the triglycerides or the cholesterol. |
| PubMedID- 25554536 | Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease. |
| PubMedID- 20959955 | Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 26246459 | Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the american heart association and the american diabetes association. |
| PubMedID- 19754853 | Methods: cardiovascular disease patients with diabetes mellitus (group a, n = 14) and nondiabetic patients with cvd only (group b, n = 10) took atorvastatin 80 mg per day for a period of 8-10 weeks. |
| PubMedID- 24918803 | Interventions targeted at modifiable risk factors, such as smoking cessation and management of hypertension and dyslipidemia, reduce the risk of cardiovascular disease (cvd) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22093212 | Background: more intensive glycemic control reduces the risk of microvascular disease in patients with diabetes mellitus but has not been proven to reduce the risk of macrovascular events such as myocardial infarction and stroke. |
| PubMedID- 25391871 | Conclusion: a decrease of hdl-c may play an important role in the course of carotid artery plaque induced by diabetes mellitus in patients with ischemic cerebral vascular disease. |
| PubMedID- 22994940 | Our empirical strategy starts with a basic model construct (model 1) that uses control variables such as age, sex, previously diagnosed disease, and health problems (diabetes mellitus, risk of vascular disease, vascular disease, musculoskeletal disease, digestive disease, mental illness, other diseases, and report of an accident in the last 12 months). |
| PubMedID- 20228404 | Background: we investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease. |
| PubMedID- 24187621 | Risk of cardiovascular diseases in diabetes mellitus and serum concentration of asymmetrical dimethylarginine. |
| PubMedID- 24977070 | Patients were excluded for the following reasons: age over 75 or under 55, previous surgery to the index joint, inflammatory arthritis, relevant comorbidity (tumors, diabetes mellitus, history of respiratory disease, cardiovascular disease, mental health problems, musculoskeletal system diseases, previous endocrinological diagnosis) or refusal to answer to the questionnaires. |
| PubMedID- 26083376 | Pioglitazone has shown to have beneficial effect on cardiovascular diseases in patients with type 2 diabetes mellitus . |
| PubMedID- 26473035 | Moreover, microalbuminuria is associated with cardiovascular disease in patients with diabetes mellitus . |
| PubMedID- 23433125 | Simultaneous pancreas-kidney transplantation (spk) is an advanced treatment option for type 1 diabetes mellitus (dm) patients with microvascular disease including nephropathy. |
| PubMedID- 22474525 | A therapeutic effect of myricetin in patients with cardiovascular diseases associated with diabetes mellitus has also been reported . |
| PubMedID- 24094079 | The risk of cardiovascular disease in diabetes mellitus is pushed sharply higher by hypercholesterolemia, especially elevated low-density lipoprotein cholesterol (ldl-c). |
| PubMedID- 24582090 | Cardiovascular disease in diabetes mellitus: risk factors and medical therapy. |
| PubMedID- 20934769 | Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 22440125 | Microalbuminuria is one of the strongest predictors of both adverse renal and cardiovascular disease (cvd) outcomes in patients with type 2 diabetes mellitus. |
| PubMedID- 25526571 | Key words: vitamin d, diabetes mellitus, deficiency of vitamin d, cancer, cardiovascular diseases, muscle physiology. |
| PubMedID- 20701768 | Risk factor reduction is the most important therapy for primary and secondary prevention of macrovascular disease in patients with and without diabetes mellitus. |
| PubMedID- 26491340 | Background: hypertension is a highly prevalent risk factor for cardiovascular disease in patients with type 1 diabetes mellitus. |
| PubMedID- 25201910 | Rationale: diabetes mellitus increases cardiovascular disease risk in humans and remains elevated despite cholesterol-lowering therapy with statins. |